María
Rodríguez Remírez
Ikertzailea 2022-(e)ra arte
![Foto de María](/img/nophoto.png)
![Foto de Stanford University School of Medicine](/img/noimage_org.png)
Stanford University School of Medicine
Stanford, Estados UnidosStanford University School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1